NSUN2‑mediated epitranscriptomic and ubiquitin modulation of Nipah virus matrix protein reveals a dual-targeting antiviral strategy
Protein & Cell · 2026
DOI: 10.1093/procel/pwag003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Protein & Cell, 2026. Verfasst von Haojie Hao und 14 weiteren Autor:innen. Beteiligte Einrichtung: Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China. Hauptthemen laut MEDLINE: Nipah Virus, Methyltransferases, Viral Matrix Proteins, Viral Nonstructural Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, the National Natural Science Foundation of China, the Strategic Priority Research Program of the CAS.
Abstract (Originalsprache)
Nipah virus (NiV) poses a significant public health threat due to its high mortality rate and the absence of approved treatments. Nonetheless, the host–virus interactions underlying its pathogenesis remain poorly understood. Here, we identified the 5-methylcytosine (m5C) methyltransferase NSUN2 as a critical host factor hijacked by NiV to facilitate replication via dual mechanisms. The viral matrix (M) protein stabilizes NSUN2 by inhibiting its proteasomal degradation. In turn, NSUN2 catalyzes m5C deposition on NiV RNAs, enhancing M RNA stability and protein expression. Simultaneously, NSUN2’s noncatalytic domain engages GNB2 as an adaptor to facilitate the recruitment of the E3 ubiquitin ligase TRIM28 to M, promoting M ubiquitination and consequent nuclear export for virion assembly. Targeting both pathways using the proteasome inhibitor carfilzomib and the m5C inhibitor MY-1B suppressed NiV replication in vitro and in hamsters. Our findings uncover a dual epigenetic–posttranslational regulatory axis exploited by NiV and present a promising combinatorial therapeutic approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China.
- Hubei JiangXia Laboratory, Wuhan 430200, China.
- College of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, China.
ORCID-Profile: Haibin Liu, Wuxiang Guan
Förderung
- National Key Research and Development Program of China
- the National Natural Science Foundation of China
- the Strategic Priority Research Program of the CAS
- the Natural Science Foundation of Hubei Province
- the Health Commission of Hubei Province scientific research Project
- the Hubei Jiangxia Laboratory Biosafety Key R&D Project
- the Hubei Provincial Young Scientific and Technological Talent Development Program
- the Natural Science Foundation of Wuhan
Zitieren
APA
Hao, H., Chen, Z., Zhang, F., Huang, Y., Luo, F., Zuo, L., Luo, T., Wang, X., Shang, C., Shan, C., Liu, H., Zhang, X., Yuan, Z., Huang, F., & Guan, W. (2026). NSUN2‑mediated epitranscriptomic and ubiquitin modulation of Nipah virus matrix protein reveals a dual-targeting antiviral strategy. Protein & Cell. https://doi.org/10.1093/procel/pwag003
Vancouver
Hao H, Chen Z, Zhang F, Huang Y, Luo F, Zuo L, et al. NSUN2‑mediated epitranscriptomic and ubiquitin modulation of Nipah virus matrix protein reveals a dual-targeting antiviral strategy. Protein & Cell. 2026. doi:10.1093/procel/pwag003
BibTeX
@article{Hao2026,
author = {Hao, Haojie and Chen, Zhen and Zhang, Fang and Huang, Yanling and Luo, Fuyu and Zuo, Li and Luo, Ting and Wang, Xiaoxue and Shang, Caiyun and Shan, Chao and Liu, Haibin and Zhang, Xueyan and Yuan, Zhiming and Huang, Fang and Guan, Wuxiang},
title = {NSUN2‑mediated epitranscriptomic and ubiquitin modulation of Nipah virus matrix protein reveals a dual-targeting antiviral strategy},
journal = {Protein & Cell},
year = {2026},
doi = {10.1093/procel/pwag003}
}
EUVIMED